Risk and Consequences of Chemotherapy-Induced Neutropenic Complications in Patients Receiving Daily Filgrastim: The Importance of Duration of Prophylaxis
BMC Health Services Research - United Kingdom
doi 10.1186/1472-6963-14-189
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 27, 2014
Authors
Publisher
Springer Science and Business Media LLC